These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30718230)

  • 1. Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis.
    Wakahashi K; Minagawa K; Kawano Y; Kawano H; Suzuki T; Ishii S; Sada A; Asada N; Sato M; Kato S; Shide K; Shimoda K; Matsui T; Katayama Y
    Blood; 2019 Apr; 133(15):1619-1629. PubMed ID: 30718230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
    Chagraoui H; Wendling F; Vainchenker W
    Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
    Wagner-Ballon O; Chagraoui H; Prina E; Tulliez M; Milon G; Raslova H; Villeval JL; Vainchenker W; Giraudier S
    J Immunol; 2006 Jun; 176(11):6425-33. PubMed ID: 16709799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
    Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
    Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis.
    Decker M; Martinez-Morentin L; Wang G; Lee Y; Liu Q; Leslie J; Ding L
    Nat Cell Biol; 2017 Jun; 19(6):677-688. PubMed ID: 28481328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis.
    Bianchi E; Ruberti S; Rontauroli S; Guglielmelli P; Salati S; Rossi C; Zini R; Tagliafico E; Vannucchi AM; Manfredini R
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG).
    Wang JC; Hemavathy K; Charles W; Zhang H; Dua PK; Novetsky AD; Chang T; Wong C; Jabara M
    Exp Hematol; 2004 Oct; 32(10):905-10. PubMed ID: 15504545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis.
    Kramann R; Schneider RK
    Blood; 2018 May; 131(19):2111-2119. PubMed ID: 29572380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
    Maekawa T; Osawa Y; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Saga R; Kato S; Yamamura T; Watanabe J; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Kimura F
    Leukemia; 2017 Dec; 31(12):2709-2716. PubMed ID: 28386106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone: a key aspect to understand phenomena in clinical hematology.
    Wakahashi K; Katayama Y
    J Bone Miner Metab; 2020 Mar; 38(2):145-150. PubMed ID: 31897749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis.
    Shinoda D; Nakajima-Takagi Y; Oshima M; Koide S; Aoyama K; Saraya A; Harada H; Rahmutulla B; Kaneda A; Yamaguchi K; Furukawa Y; Koseki H; Shimoda K; Tanaka T; Sashida G; Iwama A
    Leukemia; 2022 Feb; 36(2):452-463. PubMed ID: 34497325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Arrestin2 mediates progression of murine primary myelofibrosis.
    Rein LA; Wisler JW; Kim J; Theriot B; Huang L; Price T; Yang H; Chen M; Chen W; Sipkins D; Fedoriw Y; Walker JK; Premont RT; Lefkowitz RJ
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
    Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
    Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on Osteosclerotic Progression in Primary Myelofibrosis.
    Spampinato M; Giallongo C; Romano A; Longhitano L; La Spina E; Avola R; Scandura G; Dulcamare I; Bramanti V; Di Rosa M; Vicario N; Parenti R; Li Volti G; Tibullo D; Palumbo GA
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis.
    Longhitano L; Tibullo D; Vicario N; Giallongo C; La Spina E; Romano A; Lombardo S; Moretti M; Masia F; Coda ARD; Venuto S; Fontana P; Parenti R; Li Volti G; Di Rosa M; Palumbo GA; Liso A
    Aging (Albany NY); 2021 Dec; 13(23):25055-25071. PubMed ID: 34905501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.
    Yachoui R; Kristianto J; Sitwala K; Blank RD
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3971-4. PubMed ID: 26358171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.
    Kakumitsu H; Kamezaki K; Shimoda K; Karube K; Haro T; Numata A; Shide K; Matsuda T; Oshima K; Harada M
    Leuk Res; 2005 Jul; 29(7):761-9. PubMed ID: 15927672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis.
    Leimkühler NB; Gleitz HFE; Ronghui L; Snoeren IAM; Fuchs SNR; Nagai JS; Banjanin B; Lam KH; Vogl T; Kuppe C; Stalmann USA; Büsche G; Kreipe H; Gütgemann I; Krebs P; Banz Y; Boor P; Tai EW; Brümmendorf TH; Koschmieder S; Crysandt M; Bindels E; Kramann R; Costa IG; Schneider RK
    Cell Stem Cell; 2021 Apr; 28(4):637-652.e8. PubMed ID: 33301706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.
    Bock O; Loch G; Schade U; Büsche G; Wasielewski R; Wiese B; Kreipe H
    Br J Haematol; 2005 Jul; 130(1):76-82. PubMed ID: 15982347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.